Reliv' International (RELV) 10-K 24 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Mar. 06, 2015	Jun. 30, 2014
Document Information [Line Items]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	RELIV INTERNATIONAL INC
Entity Central Index Key	768710
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$12.90
Trading Symbol	RELV
Entity Common Stock, Shares Outstanding		12,819,110

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$4,989,392	$6,656,798
Accounts receivable, less allowances of $26,300 in 2014 and $31,800 in 2013	265,530	148,630
Accounts due from employees and distributors	121,208	129,852
Inventories:
Finished goods	3,782,171	3,516,079
Raw materials	1,216,031	1,501,522
Sales aids and promotional materials	179,263	197,089
Total inventories	5,177,465	5,214,690
Refundable income taxes	257,577	0
Prepaid expenses and other current assets	661,038	697,099
Deferred income taxes	61,000	309,000
Total current assets	11,533,210	13,156,069
Other assets	295,929	277,770
Cash surrender value of life insurance	2,747,944	2,403,763
Note receivable due from distributor	1,732,982	1,829,827
Deferred income taxes	686,000	0
Intangible assets, net	2,925,775	3,195,903
Property, plant, and equipment	18,945,772	18,541,296
Less accumulated depreciation	12,019,802	11,805,877
Property, plant, and equipment, net	6,925,970	6,735,419
Total assets	26,847,810	27,598,751
Current liabilities:
Accounts payable and accrued expenses	5,187,057	5,868,783
Income taxes payable	0	199,558
Current maturities of long-term debt	697,423	581,004
Total current liabilities	5,884,480	6,649,345
Noncurrent liabilities:
Revolving line of credit	500,000	1,150,000
Long-term debt, less current maturities	3,047,267	2,631,607
Noncurrent deferred income taxes	0	127,000
Other noncurrent liabilities	418,785	910,327
Total noncurrent liabilities	3,966,052	4,818,934
Stockholders' equity:
Preferred stock, par value $0.001 per share; 3,000,000 shares authorized; -0- shares issued and outstanding in 2014 and 2013	0	0
Common stock, par value $0.001 per share; 30,000,000 shares authorized, 14,673,083 shares issued and 12,819,110 shares outstanding in 2014; 14,519,605 shares issued and 12,665,632 shares outstanding in 2013	14,673	14,520
Additional paid-in capital	30,321,598	30,101,069
Accumulated deficit	-7,434,595	-8,159,164
Accumulated other comprehensive loss:
Foreign currency translation adjustment	-565,838	-487,393
Treasury stock	-5,338,560	-5,338,560
Total stockholders' equity	16,997,278	16,130,472
Total liabilities and stockholders' equity	$26,847,810	$27,598,751

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Allowance for accounts receivable (in dollars)	$26,300	$31,800
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares, issued	14,673,083	14,519,605
Common stock, shares, outstanding	12,819,110	12,665,632

Consolidated_Statements_of_Net

Consolidated Statements of Net Income and Comprehensive Income (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Product sales	$52,902,254	$62,379,450
Handling & freight income	4,442,705	5,827,288
Net sales	57,344,959	68,206,738
Costs and expenses:
Cost of products sold	11,657,728	14,022,996
Distributor royalties and commissions	20,542,905	24,926,014
Selling, general, and administrative	25,048,596	27,755,483
Income from operations	95,730	1,502,245
Other income (expense):
Interest income	131,503	149,402
Interest expense	-100,142	-82,461
Other income (expense)	-150,522	-137,596
Income (loss) before income taxes	-23,431	1,431,590
Provision (benefit) for income taxes	-748,000	655,000
Net income available to common shareholders	724,569	776,590
Other comprehensive income (loss):
Foreign currency translation adjustment	-78,445	7,157
Comprehensive income	$646,124	$783,747
Earnings per common share - Basic (in dollars per share)	$0.06	$0.06
Weighted average shares (in shares)	12,666,000	12,619,000
Earnings per common share - Diluted (in dollars per share)	$0.06	$0.06
Weighted average shares (in shares)	12,811,000	12,816,000

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders’ Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]
Balance at Dec. 31, 2012	$15,581,870	$14,512	$30,074,801	($8,557,178)	($494,550)	($5,455,715)
Balance (in shares) at Dec. 31, 2012		14,511,816				1,892,176
Net income	776,590	0	0	776,590	0	0
Other comprehensive income (loss):
Foreign currency translation adjustment	7,157	0	0	0	7,157	0
Total comprehensive income	783,747
Common stock dividends paid, $0.03 per share	-378,576	0	0	-378,576	0	0
Stock-based compensation	41,745	0	41,745	0	0	0
Expired stock options & warrants; deferred tax effect	-31,618	0	-31,618	0	0	0
Contribution of treasury shares to ESOP	125,000	0	2,481	0	0	122,519
Contribution of treasury shares to ESOP (in shares)		0				-42,248
Warrants exercised	13,668	8	13,660	0	0	0
Warrants exercised (in shares)		7,789				0
Common stock purchased for treasury	-5,364	0	0	0	0	-5,364
Common stock purchased for treasury (in shares)		0				4,045
Balance at Dec. 31, 2013	16,130,472	14,520	30,101,069	-8,159,164	-487,393	-5,338,560
Balance (in shares) at Dec. 31, 2013		14,519,605				1,853,973
Net income	724,569	0	0	724,569	0	0
Other comprehensive income (loss):
Foreign currency translation adjustment	-78,445	0	0	0	-78,445	0
Total comprehensive income	646,124
Stock-based compensation	46,370	0	46,370	0	0	0
Expired stock options & warrants; deferred tax effect	-2,187	0	-2,187	0	0	0
Common stock issued to consultant	176,499	153	176,346	0	0	0
Common stock issued to consultant (in shares)		153,478				0
Balance at Dec. 31, 2014	$16,997,278	$14,673	$30,321,598	($7,434,595)	($565,838)	($5,338,560)
Balance (in shares) at Dec. 31, 2014		14,673,083				1,853,973

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating activities
Net income	$724,569	$776,590
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	961,731	952,660
Stock-based compensation	46,370	41,745
Non-cash life insurance policy accretion	-91,932	-68,093
Contribution of treasury shares to ESOP	0	125,000
Deferred income taxes	-615,000	-137,000
Foreign currency transaction (gain)/loss	136,999	126,188
(Increase) decrease in accounts receivable and accounts due from employees and distributors	-117,064	84,248
(Increase) decrease in inventories	-76,392	-3,500
(Increase) decrease in refundable income taxes	-257,533	11,151
(Increase) decrease in prepaid expenses and other current assets	28,130	-23,393
(Increase) decrease in other assets	-18,159	-71,748
Increase (decrease) in income taxes payable	-199,558	199,558
Increase (decrease) in accounts payable & accrued expenses and other non-current liabilities	-913,885	508,761
Net cash (used in) provided by operating activities	-391,724	2,522,167
Investing activities
Proceeds from sale of property, plant, and equipment	1,186	3,231
Purchase of property, plant, and equipment	-909,403	-382,580
Payments received on distributor note receivable	91,219	78,954
Acquisition of lunasin technology license	0	-1,150,000
Payment of life insurance premiums	-252,250	-252,250
Net cash used in investing activities	-1,069,248	-1,702,645
Financing activities
Proceeds from revolving line of credit borrowings	500,000	1,150,000
Principal payments on long-term borrowings	-633,257	-630,246
Common stock dividends paid	0	-378,576
Proceeds from warrants exercised	0	13,668
Purchase of stock for treasury	0	-5,364
Net cash (used in) provided by financing activities	-133,257	149,482
Effect of exchange rate changes on cash and cash equivalents	-73,177	-113,248
Increase (decrease) in cash and cash equivalents	-1,667,406	855,756
Cash and cash equivalents at beginning of year	6,656,798	5,801,042
Cash and cash equivalents at end of year	4,989,392	6,656,798
Supplemental disclosures of cash flow information:
Cash paid during the year for: Interest	82,768	74,767
Cash paid during the year for: Income taxes	320,000	579,000
Noncash investing and financing transactions:
Obligation for acquisition of lunasin technology license	$0	$850,000

Nature_of_Business_and_Signifi

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
AccountingPoliciesAbstract [Abstract]
Business Description And Accounting Policies [Text Block]	1. Nature of Business and Significant Accounting Policies
	Nature of Business
	Reliv’ International, Inc. (the Company) produces a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. These products are sold by subsidiaries of the Company to a sales force of independent distributors of the Company that sell products directly to consumers. The Company and its subsidiaries sell products to distributors throughout the United States and in Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its foreign and domestic subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain reclassifications have been made to the 2013 financial statements to conform to the 2014 presentation.
	Cash Equivalents
	The Company's policy is to consider the following as cash and cash equivalents: demand deposits and short-term investments with a maturity of three months or less when purchased.
	Inventories
	Inventories are valued at the lower of cost or market. Product cost includes raw materials, labor, and overhead costs and is accounted for on a first-in, first-out basis. On a periodic basis, the Company reviews its inventory levels, as compared to future demand requirements and the shelf life of the various products. Based on this review, the Company records inventory write-downs when necessary.
	Sales aids and promotional materials inventories represent distributor kits, product brochures, and other sales and business development materials which are held for sale to distributors. Cost of the sales aids and promotional materials held for sale are capitalized as inventories and subsequently recorded to cost of goods sold upon recognition of revenue when sold to distributors. All other advertising and promotional costs are expensed when incurred.
	Property, Plant, and Equipment
	Property, plant, and equipment are stated on the cost basis. Depreciation is computed using the straight-line or an accelerated method over the useful life of the related assets. Generally, computer equipment and software are depreciated over 5 years, office equipment and machinery over 7 years, and real property over 39 years.
	Foreign Currency Translation and Transaction Gains or Losses
	All balance sheet accounts have been translated using the exchange rates in effect at the balance sheet date. Statements of income amounts have been translated using the average exchange rate for the year. The gains and losses resulting from the changes in exchange rates from year to year have been reported in other comprehensive income (loss). The foreign currency translation adjustment is the only component of accumulated other comprehensive loss. If applicable, foreign currency translation adjustments exclude income tax expense (benefit) as certain of the Company’s investments in non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time. Transaction losses were $136,999 and $126,188 for 2014 and 2013, respectively.
	Revenue Recognition
	The Company receives payment by credit card, personal check, or guaranteed funds for orders from independent distributors and makes related commission payments in the following month. Generally, net sales reflect product sales less the distributor discount of 20 percent to 40 percent of the suggested retail price. Sales revenue and commission expenses are recorded when the merchandise is shipped, as this is the point title and risk of loss pass to the distributor. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 605-50, “Revenue Recognition – Customer Payments and Incentives,” the Company presents distributor royalty and commission expense as an operating expense, rather than a reduction to net sales, as these payments are not made to the purchasing distributor.
	Actual and estimated sales returns are classified as a reduction of net sales. The Company estimates and accrues a reserve for product returns based on the Company’s return policy and historical experience. The Company’s return policy allows for distributors to return product only upon termination of his or her distributorship. Allowable returns are limited to saleable product which was purchased within twelve months of the termination for a refund of 90% of the original purchase price less any distributor royalties and commission received relating to the original purchase of the returned products. For the years ended December 31, 2014 and 2013, total returns as a percent of net sales were approximately 0.25 % and 0.57%, respectively.
	The Company records handling and freight income as a component of net sales and records handling and freight costs as a component of cost of products sold. Total revenues do not include sales tax as the Company considers itself a pass-through conduit for collecting and remitting applicable sales taxes.
	Fair Value Measurements
	FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, establishes a framework for measuring fair value, and requires disclosures about fair value measurements required under other accounting pronouncements. See Note 5 for further discussion.
	Basic and Diluted Earnings per Share
	Basic earnings per common share are computed using the weighted average number of common shares outstanding during the year. Diluted earnings per common share are computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock. See Note 8 for additional information regarding earnings per share.
	Stock-Based Compensation
	The Company has stock-based incentive plans under which it may grant stock option, restricted stock, and unrestricted stock awards. The Company recognizes stock-based compensation expense based on the grant date fair value of the award and the related vesting terms. The fair value of stock-based awards is primarily determined using the Black-Scholes model, which incorporates assumptions regarding the risk-free interest rate, expected volatility, expected option life, and dividend yield. See Note 7 for additional information.
	The Company accounts for options granted to non-employees and warrants granted to distributors under the fair value approach required by FASB ASC Topic 505-50, “Equity Based Payments to Non-Employees.”
	Income Taxes
	The provision for income taxes is computed using the liability method. The primary differences between financial statement and taxable income result from financial statement accruals and reserves and differences between depreciation and stock options for book and tax purposes.
	Unrecognized tax benefits are accounted for as required by FASB ASC Topic 740 which prescribes a more likely than not threshold for financial statement presentation and measurement of a tax position taken or expected to be taken in a tax return. See Note 11 for further discussion.
	Advertising
	Costs of sales aids and promotional materials are capitalized as inventories. All other advertising and promotional costs are expensed when incurred. The Company recorded $19,400 and $191,800 of advertising expense in 2014 and 2013, respectively.
	Research and Development Expenses
	Research and development expenses, which are charged to selling, general, and administrative expenses as incurred, were $618,000 and $565,000 in 2014 and 2013, respectively.
	Amortizable Intangible Assets
	The Company records intangible assets based on management’s determination of the fair value of the respective assets at the time of acquisition. Determining the fair value of intangible assets is judgmental and involves the use of significant estimates and assumptions of future company operations. The Company bases its fair value estimates and related asset lives on assumptions it believes to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from these estimates.
	Intangible assets estimated to have finite estimable lives are amortized over their estimated economic life under the straight-line method; such method correlates to management’s estimate of the assets’ economic benefit. Based on management’s estimates at origination, these lives range from two to seventeen years. Related amortization expense is presented within Selling, General, and Administrative in the accompanying consolidated statements of net income and comprehensive income. As of December 31, 2014, remaining lives of intangible assets range from two to sixteen years.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
	Recent Accounting Standards Pending Adoption
	In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing U.S. GAAP revenue recognition guidance and becomes effective for the Company on January 1, 2017. Early application is not permitted. The Company is currently evaluating the effect, if any, that the updated standard will have on its consolidated financial statements and related disclosures, as well as its adoption of either the retrospective or modified retrospective transition method.
	In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which requires management to assess, at each annual and interim reporting period, the entity’s ability to continue as a going concern within one year from the date the financial statements are issued and provide related disclosures. The new standard will be effective for the Company for the annual reporting period ending December 31, 2016, with early adoption permitted. This standard is not currently expected to have a material effect on the Company’s financial statement disclosures upon adoption, though the ultimate impact will be dependent on the Company’s financial condition and expected operating outlook at such time.

Property_Plant_and_Equipment

Property, Plant, and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	2. Property, Plant, and Equipment
	Property, plant, and equipment at December 31, 2014 and 2013, consist of the following:
		2014		2013
	Land and land improvements	$	883,563	$	883,563
	Building		9,966,748		9,945,187
	Machinery and equipment		4,355,040		3,785,949
	Office equipment		1,235,192		1,236,303
	Computer equipment and software		2,505,229		2,690,294
			18,945,772		18,541,296
	Less accumulated depreciation		12,019,802		11,805,877
		$	6,925,970	$	6,735,419
	For the years ended December 31, 2014 and 2013, depreciation expense was $691,603 and $750,267, respectively.

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	3. Accounts Payable and Accrued Expenses
	Accounts payable and accrued expenses at December 31, 2014 and 2013, consist of the following:
		2014		2013
	Trade payables	$	2,026,198	$	2,968,814
	Distributors' commissions		1,753,908		2,033,727
	Sales taxes		292,188		311,049
	Payroll, payroll taxes, and incentive compensation		1,114,763		555,193
		$	5,187,057	$	5,868,783

Amortizable_Intangible_Assets

Amortizable Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	4. Amortizable Intangible Assets
	The Company had amortizable intangible assets as follows as of December 31, 2014 and 2013:
						Accumulated
		Gross Carrying Amount				Amortization
		2014		2013		2014		2013
	Distributorship and related agreements	$	2,060,000	$	2,060,000	$	924,385	$	770,375
	Lunasin technology license		1,954,661		1,954,661		164,501		48,383
		$	4,014,661	$	4,014,661	$	1,088,886	$	818,758
	Amortization expense for intangible assets totaled $270,128 and $202,393 in 2014 and 2013, respectively. Amortization expense for amortizable intangible assets over the next five years is estimated to be:
		Intangible
		Amortization
	2015	$	270,000
	2016		255,000
	2017		226,000
	2018		226,000
	2019		226,000

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholdersb Equity [Parenthetical] (USD $)	12 Months Ended
	Dec. 31, 2013
Comman stock dividends paid (in dollars per share)	$0.03

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	5. Fair Value of Financial Instruments
	The carrying amount and fair value of financial instruments at December 31, 2014 and 2013 were approximately as follows:
			Carrying		Fair
	Description		Amount		Value		Level 1		Level 2		Level 3
	31-Dec-14
	Long-term debt		$	4,244,690	$	4,244,690		-	$	4,244,690	-
	Note receivable			1,829,827		2,098,000		-		2,098,000
	Marketable securities			284,000		284,000	$	284,000		-	-
	31-Dec-13
	Long-term debt		$	4,362,611	$	4,362,611		-	$	4,362,611
	Note receivable			1,921,046		2,365,000		-		2,365,000	-
	Marketable securities			278,000		278,000	$	278,000		-	-
	Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels:
		Level 1:	Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
		Level 2:	Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active.
		Level 3:	Unobservable inputs that reflect the reporting entity’s own assumptions.
	Long-term debt: The fair value of the Company’s term and revolver loans approximate carrying value as these loans have variable market-based interest rates that reset every thirty days. The fair value of the Company’s obligation for the acquisition of its lunasin technology license approximates carrying value as this obligation is a zero-interest based obligation discounted utilizing an interest rate factor comparable to the Company’s market-based interest rate of its term and revolver loans.
	Note receivable: The Company’s note receivable is a variable rate residential mortgage-based financial instrument. An average of published interest rate quotes for a fifteen-year residential jumbo mortgage, a comparable financial instrument, was used to estimate fair value of this note receivable under a discounted cash flow model.
	Marketable securities: The assets (trading securities) of the Company’s Supplemental Executive Retirement Plan are recorded at fair value on a recurring basis, and are presented within Other Assets in the consolidated balance sheets.
	The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of the respective balances.

Debt

Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Long-term Debt [Text Block]	6. Debt
	Debt at December 31, 2014 and 2013 consists of the following:
		2014		2013
	Term loan	$	3,067,442	$	2,400,697
	Revolving line of credit		500,000		1,150,000
	Obligation for acquisition of technology license, net		677,248		811,914
			4,244,690		4,362,611
	Less current maturities		697,423		581,004
	Long-term portion	$	3,547,267	$	3,781,607
	Principal maturities of debt at December 31, 2014, are as follows:
	2015	$	697,423
	2016		3,320,019
	2017		227,248
	2018		-
	2019		-
	Thereafter		-
		$	4,244,690
	Revolving loan agreements
	Effective September 30, 2012, the Company entered into a new one-year $5 million revolving loan agreement (2012) with its primary lender. Similar to the previous agreements, any advances under the revolver accrue interest at a variable interest rate based on 30-day LIBOR + 1.85%. Interest, if any, is payable monthly. In August 2013, in conjunction with its acquisition of a technology license, the Company borrowed $1.15 million under its revolving line of credit and this balance remained outstanding at December 31, 2013.
	On February 28, 2014, the Company and its primary lender amended the revolving line of credit agreement and the term loan agreement (collectively, the “Credit Agreement”). As part of the amendment, the $5 million revolving line of credit agreement was extended to July 1, 2016 and the outstanding revolving loan balance of $1.15 million was re-financed into the term loan balance.
	In September 2014, the Company borrowed $500,000 under its revolving line of credit to finance the purchase of machinery and equipment. On October 29, 2014, in conjunction with its amendment to the Credit Agreement, the Company and its primary lender amended the maximum borrowing capacity of the revolving line of credit from $5 million to $3.5 million. At December 31, 2014, the revolver’s interest rate was 2.008% and $3 million remains available for additional borrowings under the revolving line of credit.
	Term Loan
	On September 30, 2012, the Company re-financed a prior loan agreement with its primary lender. The 2012 re-financed term loan was for a period of thirty-eight months with interest accruing at a floating interest rate based on the 30-day LIBOR plus 2%. Monthly principal and interest payments were based on approximately a seven-year amortization with the aggregate outstanding balance of principal and interest due and payable on November 30, 2015.
	On February 28, 2014, the Company re-financed the 2012 term loan agreement and its revolving line of credit agreement with its primary lender. The 2014 re-financed term loan is for a period of twenty-eight months with the same floating interest rate pricing as the 2012 term loan. The total borrowings on the new 2014 term loan was approximately $3.5 million and consisted of the summation of the outstanding balance of the 2012 term loan plus the February 28, 2014 revolving line of credit loan balance of $1.15 million. Monthly term loan payments consist of principal of $41,452 plus interest with a balloon payment for the outstanding balance due and payable on July 1, 2016. At December 31, 2014, the term loan’s interest rate was 2.158%.
	The Credit Agreement is secured by all tangible and intangible assets of the Company and also by a mortgage on the real estate of the Company’s headquarters. The Credit Agreement also includes loan covenants requiring the Company to maintain net tangible worth of not less than $11 million, and a fixed charge coverage ratio under which EBITDA adjusted for certain non-cash expenses shall exceed fixed charges by a ratio of at least 1.15 to 1. Fixed charges, as defined, include unfinanced capital expenditures, dividends and other distributions, cash taxes paid, and principal and interest due on all debt obligations. At September 30, 2014, the Company’s fixed charge coverage ratio was less than the loan covenant’s minimum ratio of 1.15 to 1. On October 29, 2014, the Company and its primary lender agreed to amend the Credit Agreement whereby the primary lender waived the Company’s non-compliance with the fixed charge coverage ratio for the September 30, 2014 reporting period.
	In addition to the aforementioned loan covenant waiver and the reduction in the maximum borrowing capacity of the revolver, the October 29, 2014 amendment restricts the Company from the declaration and cash payment of common stock dividends and the repurchase of company common stock.
	At December 31, 2014, the Company’s fixed charge coverage ratio was less than the loan covenant’s minimum ratio of 1.15 to 1. On February 27, 2015, the Company’s primary lender waived the Company’s non-compliance with the fixed charge coverage ratio for the December 31, 2014 reporting period. On March 3, 2015, the Company and its primary lender entered into the Second Amendment to the Credit Agreement whereby the parties agreed to adjust the minimum fixed coverage ratio to 1.0 for the March 31, 2015 reporting period, only. Quarterly loan covenant reporting periods subsequent to March 31, 2015 remain at a minimum fixed coverage ratio of 1.15 to 1.0.
	In addition, the Second Amendment revises the net tangible worth covenant to a covenant minimum of $9.5 million and re-defines net tangible worth as actual stockholders’ equity reduced by the sum of net intangible assets, accounts due from employees and distributors, and note receivable due from distributor.
	Obligation for Acquisition of Technology License, net
	In July 2013, a newly-formed, wholly-owned subsidiary of the Company entered into a Technology License Agreement (TLA) with a privately-held company. The TLA provides the Company the exclusive license for certain intellectual property related to the nutritional ingredient lunasin and other soy-related peptides and proteins. In consideration for the TLA, the Company agreed to pay the licensor a purchase price of $2 million; $1.15 million paid at closing, with the remaining obligation (non-interest bearing) paid over the next four years in a series of annual payments ranging from $150,000 to $250,000 as stated in the agreement. Subject to certain minimum and maximum thresholds, the Company may also pay the licensor royalties of 5% of sales during the first five years of the TLA and royalties ranging from 1% to 3% of sales during the remaining life of the TLA. As of December 31, 2014, management’s estimate of earned but unpaid royalties is zero. The Company has accounted for the TLA as an asset purchase acquisition consisting of a long-term finite-lived asset to be amortized over the life of the associated intellectual property (approximately seventeen years at origination).

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	7. Stockholders’ Equity
	Stock Options
	Incentive Stock Plans
	The Company sponsors two incentive stock plans (a “2014 Plan” and a “2009 Plan”) each allowing for a maximum of 1,000,000 shares to be granted in the form of either incentive stock options, non-qualified stock options, restricted stock awards, or unrestricted stock awards. Employees, directors, advisors, and consultants of the Company are eligible to receive the grants. These plans have been approved by the stockholders of the Company. The Compensation Committee of the Board of Directors administers the plans.
	The 2014 Plan and the 2009 Plan provide that options may be issued under the plan(s) at an option price not less than fair market value of the stock at the time the option is granted. Under these plans, restricted stock of the Company may be granted at no cost to the grantee. The grantees are entitled to dividends and voting rights for their respective shares. Restrictions limit the sale or transfer of these shares during the requisite service period. In addition, the committee may grant or sell unrestricted stock at a purchase price to be determined by the committee.
	Vesting terms and restrictions, if applicable, under the plans, are set by the committee and will be 10 years or less. The 2014 Plan expires in 2024 and the 2009 Plan expires in 2019. As of December 31, 2014, there have not been any awards under the 2014 Plan.
	In March 2013, under the 2009 Plan, the Company issued performance-based stock option grants totaling 230,000 shares. These option grants have an exercise price of $1.17 per share with a five-year term. The options’ vesting provisions are contingent upon the Company achieving certain financial performance measurements. The aggregate estimated compensation cost related to the performance based options is $110,400; however, recognition is contingent upon performance vesting. The grant-date fair value of the options was $0.48 per share and was determined using a binomial lattice option pricing model using an average risk-free rate of 0.90%, an average dividend yield of 1.60%, and an average volatility of 52.7%.
	Compensation cost for all of the stock option plans was approximately $32,737 ($32,000 net of tax) and $36,772 ($35,000 net of tax) for the years ended December 31, 2014 and 2013, respectively, and has been recorded in selling, general, and administrative expense. As of December 31, 2014, the total remaining unrecognized compensation cost related to the non-vested portion of time vesting stock options totaled $60,000 ($58,000 net of tax), which will be amortized over the weighted remaining requisite service period of two years.
	A summary of the Company’s stock option activity and related information for the years ended December 31 follows:
		2014					2013
				Weighted				Weighted
				Avg.				Avg.
				Exercise				Exercise
		Options		Price			Options	Price
	Outstanding beginning of the year	1,465,000		$	3.42		1,313,500	$	3.95
	Granted	-					230,000		1.17
	Exercised	-					-
	Expired and forfeited	-83,000			2.4		-78,500		5.57
	Outstanding at end of year	1,382,000		$	3.49		1,465,000	$	3.42
	Exercisable at end of year	608,000		$	6.39		555,500	$	7.05
		As of December 31, 2014
		Options Outstanding						Options Exercisable
	Range of	Number		Weighted Avg.		Weighted Avg.		Number		Weighted Avg.		Weighted Avg.
	Exercise Prices	Outstanding		Remaining Life		Exercise Price		Exercisable		Remaining Life		Exercise Price
	$1.17	202,000		3.17		$	1.17	-		-		$	-
	$1.20 - $1.32	715,000		2			1.22	143,000		2			1.23
	$7.92	435,000		0.01			7.92	435,000		0.01			7.92
	$8.68	30,000		0.79			8.68	30,000		0.79			8.68
	$1.17 - $8.68	1,382,000		1.52		$	3.49	608,000		0.52		$	6.39
	The aggregate intrinsic value of stock options outstanding and currently exercisable at December 31, 2014 was $-0-. Intrinsic value for stock options is calculated based on the exercise price of the underlying awards as compared to the quoted price of the Company’s common stock as of the reporting date.
	For the years ended December 31, 2014 and 2013, no stock options were exercised.
	Distributor Stock Purchase Plan
	In July 2009, the Company established a Distributor Stock Purchase Plan (2009 Plan) which replaced a similar plan which had expired. Since inception, a total of 68,263 warrants have been issued under the 2009 Plan.
	The plan allows distributors who have reached the “Ambassador” status the opportunity to allocate up to 10% of their monthly compensation into the plan to be used to purchase the Company’s common stock at the current market value. The plan also states that at the end of each year, the Company will grant warrants to purchase additional shares of the Company’s common stock based on the number of shares purchased by the distributors under the plan during the year. The warrant exercise price will equal the market price for the Company’s common stock at the date of issuance. The warrants issued shall be in the amount of 25% of the total shares purchased under the plan during the year and the warrants are fully vested upon grant.
	The Company records expense under the fair value method for warrants granted to distributors. Total expense recorded for these warrants was $13,633 and $4,973 in 2014 and 2013, respectively.
	The fair value of the warrants was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions:
		Year ended December 31
		2014		2013
	Expected warrant life (years)	3		3
	Risk-free weighted average interest rate	1.1	%	0.78	%
	Stock price volatility	64.1	%	62.8	%
	Dividend yield	0	%	0.8	%
	A summary of the Company’s warrant activity and related information for the years ended December 31 follows:
		2014					2013
				Weighted				Weighted
				Avg.				Avg.
				Exercise				Exercise
		Warrants		Price			Warrants	Price
	Outstanding beginning of the year	37,987		$	1.76		41,827	$	1.49
	Granted	11,192			1.17		12,065		2.81
	Exercised	-					-7,789		1.76
	Expired	-14,154			1.23		-8,116		1.94
	Outstanding at end of year	35,025		$	1.78		37,987	$	1.76
	Exercisable at end of year	35,025					37,987
		As of December 31, 2014
		Warrants Outstanding						Warrants Exercisable
	Range of	Number		Weighted Avg.		Weighted Avg.		Number		Weighted Avg.
	Exercise Prices	Outstanding		Remaining Life		Exercise Price		Exercisable		Exercise Price
	$1.17	11,192		3		$	1.17	11,192		$	1.17
	$1.31	11,768		1			1.31	11,768			1.31
	$2.81	12,065		2			2.81	12,065			2.81
	$1.17 - $2.81	35,025		1.98		$	1.78	35,025		$	1.78
	The intrinsic value for stock warrants outstanding at December 31, 2014 was $-0-. A summary of the total intrinsic value, actual tax benefit realized, and cash received for stock warrants exercised for the years ended December 31 follows:
		Year ended December 31
	2014			2013
Stock Warrants Exercised:
Intrinsic value	$	-		$	9,548
Actual tax benefit realized		-			2,045
Cash received		-			13,668
Other equity transaction
For the years ended December 31, 2014 and 2013, the Company recorded expense and a corresponding liability for certain consulting services of $70,499 and $106,000, respectively. In December 2014, based upon the fair market value of the Company’s common stock on issuance date, the Company issued 153,478 shares of Company common stock at a fair market value of $176,499 to this consultant for services rendered.

Earnings_per_Share

Earnings per Share	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	8. Earnings per Share
	The following table sets forth the computation of basic and diluted earnings per share:
		Year ended December 31
		2014		2013
	Numerator:
	Net income	$	724,569	$	776,590
	Denominator:
	Denominator for basic earnings per share – weighted average shares		12,666,000		12,619,000
	Dilutive effect of employee stock options and other warrants		145,000		197,000
	Denominator for diluted earnings per share – adjusted weighted average shares		12,811,000		12,816,000
	Basic earnings per share	$	0.06	$	0.06
	Diluted earnings per share	$	0.06	$	0.06
	For the years ended December 31, 2014 and 2013, options and warrants totaling 1,036,565 and 1,099,565, respectively, shares of common stock were not included in the denominator for diluted earnings per share because their effect would be anti-dilutive or because the shares were deemed contingently issuable.

Leases

Leases	12 Months Ended
	Dec. 31, 2014
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	9. Leases
	The Company leases certain office facilities, storage, and equipment. These leases have varying terms, and certain leases have renewal and/or purchase options. Future minimum payments under non-cancelable leases with initial or remaining terms in excess of one year consist of the following at December 31, 2014:
	2015	$	378,841
	2016		218,665
	2017		150,478
	2018		34,764
	2019		10,272
	Thereafter		5,136
		$	798,156
	Rent expense for operating leases was $471,066 and $479,862 for the years ended December 31, 2014 and 2013, respectively.

Note_Receivable_Due_From_Distr

Note Receivable Due From Distributor	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Note Receivable Due From Distributor [Text Block]	10. Note Receivable Due From Distributor
	In March 2012, the Company purchased a note and mortgage (“Note”) from a real estate investment management firm on certain properties in Wyoming and Idaho for $2 million. In May 2012, the Company entered into a Loan Modification Agreement (“LMA”) with the Note’s original and present borrower (“Borrower”) to restructure the Note’s principal amount due and related terms. The LMA terms are for a principal balance due of $2 million with interest only payments made monthly in 2012. The LMA’s interest rate is the greater of 6% or prime and there is no prepayment penalty for voluntary principal payments. Concurrently, with the execution of the LMA, the Company and the Borrower also entered into a Security Agreement in which repayment of the LMA is secured by the Borrower’s Reliv distributorship business.
	As originally structured, beginning in 2013, the LMA was to require monthly payment of principal and interest under a five-year amortization period. In February 2013, while retaining the Company’s right to require Borrower’s compliance with the LMA’s terms, the Company and the Borrower agreed to a verbal modification in the payment schedule in which the Company agreed to accept monthly payments of principal and interest under a fifteen-year amortization period. The outstanding balance of the note receivable was $1,829,827 and $1,921,046 as of December 31, 2014 and 2013, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	11. Income Taxes
	Compenents of income (loss) before income taxes:	Year ended December 31
		2014		2013
	United States	$	49,757	$	2,974,655
	Foreign		-73,188		-1,543,065
		$	-23,431	$	1,431,590
	Compenents of provision (benefit) for income taxes:	Year ended December 31
		2014		2013
	Current:
	Federal	$	-37,000	$	652,000
	State		-122,000		117,000
	Foreign		26,000		23,000
	Total current		-133,000		792,000
	Deferred:
	Federal		131,000		-126,000
	State		24,000		-23,000
	Foreign		-770,000		12,000
	Total deferred		-615,000		-137,000
		$	-748,000	$	655,000
	The provision (benefit) for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of 34%. The reasons for these differences are as follows:
		Year ended December 31
		2014		2013
	Income taxes at U.S. statutory rate	$	-8,000	$	487,000
	State income taxes, net of federal benefit		19,000		70,000
	Higher/(lower) effective taxes on earnings in foreign countries		37,000		116,000
	Foreign corporate income taxes		14,000		35,000
	Nondeductible meals and entertainment expense		23,000		27,000
	Qualified production activities income - AJCA		-		-52,000
	State tax planning strategy		-97,000		-
	Release of valuation allowance, net		-714,000		-
	Other		-22,000		-28,000
		$	-748,000	$	655,000
	The Company has a deferred tax asset of $3,147,000 as of December 31, 2014, and $3,640,000 as of December 31, 2013, relating to foreign net operating loss carryforwards (NOLs) in various jurisdictions which expire in a range of years from one to unlimited. In 2014, the Company recorded a net income tax benefit of $758,000 due to a reduction of the valuation allowance related to deferred tax assets for net operating losses of approximately $3.6 million in the Company’s United Kingdom subsidiary. Based on management’s assessment, the Company reduced the United Kingdom’s NOL valuation allowance because the weight of evidence regarding the future realizability of the deferred tax assets had become predominantly positive and realization of the deferred tax assets was more likely than not. The positive evidence considered primarily related to three years of consistent profitability while the only negative evidence was historical losses prior to 2012 for this subsidiary. The additional change in the valuation allowance balance presented below represents the impact from foreign currency translation.
	The components of the deferred tax assets and liabilities, and the related tax effects of each temporary difference at December 31, 2014 and 2013, are as follows:
		2014		2013
	Deferred tax assets:
	Product refund reserve	$	13,000	$	26,000
	Inventory obsolescence reserve		24,000		28,000
	Vacation accrual		17,000		28,000
	Stock-based compensation		10,000		6,000
	Organization costs		208,000		207,000
	Deferred compensation		98,000		284,000
	Miscellaneous accrued expenses		8,000		16,000
	Foreign net operating loss carryforwards		3,147,000		3,640,000
	Valuation allowance - NOL carryforwards		-2,432,000		-3,640,000
			1,093,000		595,000
	Deferred tax liabilities:
	Depreciation and amortization		213,000		272,000
	Foreign currency exchange		133,000		141,000
			346,000		413,000
	Net deferred tax assets (liabilities)	$	747,000	$	182,000
	Reported as:
	Current deferred tax assets	$	61,000	$	309,000
	Non-current deferred tax assets		686,000		-
	Non-current deferred tax liabilities		-		127,000
	Net deferred tax assets	$	747,000	$	182,000
	Through December 31, 2014, the cumulative amount of unremitted earnings on which the Company has not recognized United States income tax was $57,000 as the Company plans to indefinitely reinvest these earnings outside the United States.
	The Company applied applicable accounting guidance relating to accounting for uncertainty in income taxes. Reserves for uncertainty in income taxes are adjusted quarterly in light of changing facts and circumstances, such as the progress of tax audits, case law, and emerging legislation. The primary difference between gross unrecognized tax benefits and net unrecognized tax benefits is the U.S. federal tax benefit from state tax deductions. It is the Company’s practice to recognize interest and / or penalties related to income tax matters in income tax expense.
	At December 31, 2014 and 2013, the Company had $48,000 and $91,000, respectively, of cumulative unrecognized tax benefits, of which only the net amount of 48,000 would impact the effective income tax rate if recognized.
	The aggregate changes in the balance of gross unrecognized tax benefits were as follows:
	Beginning balance as of January 1, 2013	$	56,000
	Settlements and effective settlements with tax authorities		-
	Lapse of statute of limitations		-7,000
	Increases in balances related to tax positions taken during prior periods		40,000
Decreases in balances related to tax positions taken during prior periods		-11,000
Increases in balances related to tax positions taken during current period		13,000
Balance as of December 31, 2013	$	91,000
Settlements and effective settlements with tax authorities		-
Lapse of statute of limitations		-6,000
Increases in balances related to tax positions taken during prior periods		-
Decreases in balances related to tax positions taken during prior periods		-46,000
Increases in balances related to tax positions taken during current period		9,000
Balance as of December 31, 2014	$	48,000
The Company’s unrecognized tax benefits balance is included within other noncurrent liabilities on the consolidated balance sheets.
The Company, including its domestic and foreign subsidiaries, is subject to U.S. federal income tax as well as income tax of multiple state and foreign jurisdictions. The Company has concluded all U.S. federal income tax matters for years through 2010 and concluded years through 2010 with its primary state jurisdiction.
One of the Company’s foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 plus interest at 20% per annum) in value-added tax (VAT) and withholding tax for the years 2004 through 2006. The Company, in consultation with its legal counsel, believes that there are strong legal grounds that it should not be liable to pay the majority of the alleged tax deficiencies. As of December 31, 2010, management estimated and reserved approximately $185,000 for resolution of this matter and recorded this amount within Selling, General, and Administrative expense in the 2010 Consolidated Statement of Income. In 2011, the Company made good faith deposits to the local tax authority under the tax agency’s administrative judicial resolution process. As of December 31, 2014, management’s estimated reserve (net of deposits) for this matter is approximately $122,000.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	12. Employee Benefit Plans
	The Company sponsors a 401(k) employee savings plan which covers substantially all employees. Employees can contribute up to 15% of their gross income to the plan. The Company matched a percentage of the employee’s contribution at a rate of 25% for 2013 and the first nine months of 2014 and at a rate of 10% for the last 3 months of 2014. Company contributions under the 401(k) plan totaled $98,300 and $144,600 in 2014 and 2013, respectively.
	On September 1, 2006, the Company established an employee stock ownership plan ("ESOP") which covers substantially all U.S. employees. Contributions to the ESOP are funded by the Company on a discretionary basis. In 2014, the Company elected to not make a contribution to the ESOP. In 2013, the Company’s contribution consisted of shares of common stock from treasury measured by the fair value of the stock on date of contribution. Company contributions under the ESOP plan totaled approximately $-0- and $125,000 for each of the years ended December 31, 2014 and 2013, respectively.

Incentive_Compensation_Plans

Incentive Compensation Plans	12 Months Ended
	Dec. 31, 2014
Compensation Related Costs [Abstract]
Compensation Related Costs, General [Text Block]	13. Incentive Compensation Plans
	In May 2007, the Board of Directors approved the adoption of a new incentive compensation plan. This new plan was effective for fiscal year 2007 and replaced a previous plan. Under the plan, bonuses are payable quarterly in an amount not to exceed 18% of the Company’s Income from Operations for any period, subject to the Company achieving a minimum quarterly Income from Operations of at least $500,000. For fiscal years 2014 and 2013, the Board determined that the aggregate amount of incentive compensation available under the Plan shall be equal to 16% of the Company’s Income from Operations. The bonus pool is allocated to executives according to a specified formula, with a portion allocated to a middle management group determined by the Executive Committee of the Board of Directors.
	The Company expensed a total of $89,000 and $286,000 to the participants of the bonus pool for 2014 and 2013, respectively.
	In July 2010, the Company’s Reliv Europe subsidiary entered into a long-term performance-based incentive compensation agreement with the subsidiary’s senior managers. The valuation of the compensation agreement is an EBITDA-based formula derived from the subsidiary’s financial performance and vests in 20% annual increments which began in April 2011. The amount of the incentive, if any, varies in accordance with a 24-month look-back of the subsidiary’s financial performance and the vesting provisions. Upon initial vesting, a manager may elect to exercise his/her put option to receive in cash some or all of his/her respective share of the incentive. In the fourth quarter of 2012, the subsidiary’s 24-month financial performance became positive, and remained positive throughout 2013 and 2014, resulting in the recognition of compensation expense of $137,000 and $440,500 for 2014 and 2013, respectively, as presented within Selling, General, and Administrative in the accompanying consolidated statements of net income and comprehensive income. At December 31, 2013, accrued compensation was $529,000 and was included in “Other Non-Current Liabilities” in the accompanying consolidated balance sheets.
	Beginning April 2015, the Company may exercise a call option on one or more of the manager’s incentive amount; redeeming such amount in cash or a combination of cash and the Company’s common stock, depending upon the amount of the vested incentive. At December 31, 2014, it is management’s estimate that it will exercise within one year the Company’s call option for all of the vested incentive balance at time of exercise. Accordingly, the December 31, 2014, accrued incentive compensation of $666,000 was presented in “Payroll, Payroll Taxes, and Incentive Compensation Payable”, a component of Accounts Payable and Accrued Expenses, as presented in the accompanying consolidated balance sheets.
	The Company sponsors a Supplemental Executive Retirement Plan (SERP) to allow certain executives to defer a portion of their annual salary and bonus into a grantor trust. A grantor trust was established to hold the assets of the SERP. The Company funds the grantor trust by paying the amount deferred by the participant into the trust at the time of deferral. Investment earnings and losses accrue to the benefit or detriment of the participants. The SERP also provides for a discretionary matching contribution by the Company not to exceed 100% of the participant’s annual contribution. In 2014 and 2013, the Company did not provide a match. The participants fully vest in the deferred compensation three years from the date they enter the SERP. The participants are not eligible to receive distribution under the SERP until retirement, death, or disability of the participant. At December 31, 2014 and 2013, SERP assets were $284,000 and $278,000, respectively, and are included in “Other Assets” in the accompanying consolidated balance sheets. At December 31, 2014 and 2013, SERP liabilities were $288,000 and $287,000, respectively, and are included in “Other Non-Current Liabilities” in the accompanying consolidated balance sheets. The changes in the balances of SERP assets and SERP liabilities during 2014 and 2013 were due to net realized and unrealized investment gains/losses incurred by the plan.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	14. Segment Information
	Description of Products and Services by Segment
	The Company operates in one reportable segment, a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. These operating units are based on geographic regions.
	Geographic area data for the years ended December 31, 2014 and 2013 follow:
			2014		2013
	Net sales to external customers
	United States		$	43,323,190	$	53,650,647
	Australia/New Zealand			1,641,492		1,858,983
	Canada			1,367,294		1,776,375
	Mexico			796,208		977,358
	Europe   (1)			8,300,520		7,953,221
	Asia   (2)			1,916,255		1,990,154
	Total net sales		$	57,344,959	$	68,206,738
	Assets by area
	United States		$	22,414,373	$	22,966,040
	Australia/New Zealand			609,933		807,336
	Canada			485,544		753,035
	Mexico			456,601		531,854
	Europe   (1)			2,244,738		1,665,194
	Asia   (2)			636,621		875,292
	Total consolidated assets		$	26,847,810	$	27,598,751
	-1	Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.
	-2	Asia consists of Philippines, Malaysia, Singapore, and Indonesia.
	The Company classifies its sales into three categories of sales products plus handling & freight income. Net sales by product category data for the years ended December 31, 2014 and 2013, follow:
			2014		2013
	Net sales by product category
	Nutritional and dietary supplements		$	51,144,929	$	60,049,651
	Skin care products			344,325		417,688
	Sales aids and other			1,413,000		1,912,111
	Handling & freight income			4,442,705		5,827,288
	Total net sales		$	57,344,959	$	68,206,738

Nature_of_Business_and_Signifi1

Nature of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Nature Of Operations Policy [Policy Text Block]	Nature of Business
	Reliv’ International, Inc. (the Company) produces a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. These products are sold by subsidiaries of the Company to a sales force of independent distributors of the Company that sell products directly to consumers. The Company and its subsidiaries sell products to distributors throughout the United States and in Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its foreign and domestic subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain reclassifications have been made to the 2013 financial statements to conform to the 2014 presentation.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Equivalents
	The Company's policy is to consider the following as cash and cash equivalents: demand deposits and short-term investments with a maturity of three months or less when purchased.
Inventory, Policy [Policy Text Block]	Inventories
	Inventories are valued at the lower of cost or market. Product cost includes raw materials, labor, and overhead costs and is accounted for on a first-in, first-out basis. On a periodic basis, the Company reviews its inventory levels, as compared to future demand requirements and the shelf life of the various products. Based on this review, the Company records inventory write-downs when necessary.
	Sales aids and promotional materials inventories represent distributor kits, product brochures, and other sales and business development materials which are held for sale to distributors. Cost of the sales aids and promotional materials held for sale are capitalized as inventories and subsequently recorded to cost of goods sold upon recognition of revenue when sold to distributors. All other advertising and promotional costs are expensed when incurred.
Property, Plant and Equipment, Policy [Policy Text Block]	Property, Plant, and Equipment
	Property, plant, and equipment are stated on the cost basis. Depreciation is computed using the straight-line or an accelerated method over the useful life of the related assets. Generally, computer equipment and software are depreciated over 5 years, office equipment and machinery over 7 years, and real property over 39 years.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation and Transaction Gains or Losses
	All balance sheet accounts have been translated using the exchange rates in effect at the balance sheet date. Statements of income amounts have been translated using the average exchange rate for the year. The gains and losses resulting from the changes in exchange rates from year to year have been reported in other comprehensive income (loss). The foreign currency translation adjustment is the only component of accumulated other comprehensive loss. If applicable, foreign currency translation adjustments exclude income tax expense (benefit) as certain of the Company’s investments in non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time. Transaction losses were $136,999 and $126,188 for 2014 and 2013, respectively.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	The Company receives payment by credit card, personal check, or guaranteed funds for orders from independent distributors and makes related commission payments in the following month. Generally, net sales reflect product sales less the distributor discount of 20 percent to 40 percent of the suggested retail price. Sales revenue and commission expenses are recorded when the merchandise is shipped, as this is the point title and risk of loss pass to the distributor. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 605-50, “Revenue Recognition – Customer Payments and Incentives,” the Company presents distributor royalty and commission expense as an operating expense, rather than a reduction to net sales, as these payments are not made to the purchasing distributor.
	Actual and estimated sales returns are classified as a reduction of net sales. The Company estimates and accrues a reserve for product returns based on the Company’s return policy and historical experience. The Company’s return policy allows for distributors to return product only upon termination of his or her distributorship. Allowable returns are limited to saleable product which was purchased within twelve months of the termination for a refund of 90% of the original purchase price less any distributor royalties and commission received relating to the original purchase of the returned products. For the years ended December 31, 2014 and 2013, total returns as a percent of net sales were approximately 0.25 % and 0.57%, respectively.
	The Company records handling and freight income as a component of net sales and records handling and freight costs as a component of cost of products sold. Total revenues do not include sales tax as the Company considers itself a pass-through conduit for collecting and remitting applicable sales taxes.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements
	FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, establishes a framework for measuring fair value, and requires disclosures about fair value measurements required under other accounting pronouncements. See Note 5 for further discussion.
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Earnings per Share
	Basic earnings per common share are computed using the weighted average number of common shares outstanding during the year. Diluted earnings per common share are computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock. See Note 8 for additional information regarding earnings per share.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	The Company has stock-based incentive plans under which it may grant stock option, restricted stock, and unrestricted stock awards. The Company recognizes stock-based compensation expense based on the grant date fair value of the award and the related vesting terms. The fair value of stock-based awards is primarily determined using the Black-Scholes model, which incorporates assumptions regarding the risk-free interest rate, expected volatility, expected option life, and dividend yield. See Note 7 for additional information.
	The Company accounts for options granted to non-employees and warrants granted to distributors under the fair value approach required by FASB ASC Topic 505-50, “Equity Based Payments to Non-Employees.”
Income Tax, Policy [Policy Text Block]	Income Taxes
	The provision for income taxes is computed using the liability method. The primary differences between financial statement and taxable income result from financial statement accruals and reserves and differences between depreciation and stock options for book and tax purposes.
	Unrecognized tax benefits are accounted for as required by FASB ASC Topic 740 which prescribes a more likely than not threshold for financial statement presentation and measurement of a tax position taken or expected to be taken in a tax return. See Note 11 for further discussion.
Advertising Costs, Policy [Policy Text Block]	Advertising
	Costs of sales aids and promotional materials are capitalized as inventories. All other advertising and promotional costs are expensed when incurred. The Company recorded $19,400 and $191,800 of advertising expense in 2014 and 2013, respectively.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenses
	Research and development expenses, which are charged to selling, general, and administrative expenses as incurred, were $618,000 and $565,000 in 2014 and 2013, respectively.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Amortizable Intangible Assets
	The Company records intangible assets based on management’s determination of the fair value of the respective assets at the time of acquisition. Determining the fair value of intangible assets is judgmental and involves the use of significant estimates and assumptions of future company operations. The Company bases its fair value estimates and related asset lives on assumptions it believes to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from these estimates.
	Intangible assets estimated to have finite estimable lives are amortized over their estimated economic life under the straight-line method; such method correlates to management’s estimate of the assets’ economic benefit. Based on management’s estimates at origination, these lives range from two to seventeen years. Related amortization expense is presented within Selling, General, and Administrative in the accompanying consolidated statements of net income and comprehensive income. As of December 31, 2014, remaining lives of intangible assets range from two to sixteen years.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Standards Pending Adoption
	In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing U.S. GAAP revenue recognition guidance and becomes effective for the Company on January 1, 2017. Early application is not permitted. The Company is currently evaluating the effect, if any, that the updated standard will have on its consolidated financial statements and related disclosures, as well as its adoption of either the retrospective or modified retrospective transition method.
	In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which requires management to assess, at each annual and interim reporting period, the entity’s ability to continue as a going concern within one year from the date the financial statements are issued and provide related disclosures. The new standard will be effective for the Company for the annual reporting period ending December 31, 2016, with early adoption permitted. This standard is not currently expected to have a material effect on the Company’s financial statement disclosures upon adoption, though the ultimate impact will be dependent on the Company’s financial condition and expected operating outlook at such time.

Property_Plant_and_Equipment_T

Property, Plant, and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property, plant, and equipment at December 31, 2014 and 2013, consist of the following:
		2014		2013
	Land and land improvements	$	883,563	$	883,563
	Building		9,966,748		9,945,187
	Machinery and equipment		4,355,040		3,785,949
	Office equipment		1,235,192		1,236,303
	Computer equipment and software		2,505,229		2,690,294
			18,945,772		18,541,296
	Less accumulated depreciation		12,019,802		11,805,877
		$	6,925,970	$	6,735,419

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accounts payable and accrued expenses at December 31, 2014 and 2013, consist of the following:
		2014		2013
	Trade payables	$	2,026,198	$	2,968,814
	Distributors' commissions		1,753,908		2,033,727
	Sales taxes		292,188		311,049
	Payroll, payroll taxes, and incentive compensation		1,114,763		555,193
		$	5,187,057	$	5,868,783

Amortizable_Intangible_Assets_

Amortizable Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	The Company had amortizable intangible assets as follows as of December 31, 2014 and 2013:
						Accumulated
		Gross Carrying Amount				Amortization
		2014		2013		2014		2013
	Distributorship and related agreements	$	2,060,000	$	2,060,000	$	924,385	$	770,375
	Lunasin technology license		1,954,661		1,954,661		164,501		48,383
		$	4,014,661	$	4,014,661	$	1,088,886	$	818,758
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Amortization expense for amortizable intangible assets over the next five years is estimated to be:
		Intangible
		Amortization
	2015	$	270,000
	2016		255,000
	2017		226,000
	2018		226,000
	2019		226,000

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping [Table Text Block]	The carrying amount and fair value of financial instruments at December 31, 2014 and 2013 were approximately as follows:
		Carrying		Fair
	Description	Amount		Value		Level 1		Level 2		Level 3
	31-Dec-14
	Long-term debt	$	4,244,690	$	4,244,690		-	$	4,244,690	-
	Note receivable		1,829,827		2,098,000		-		2,098,000
	Marketable securities		284,000		284,000	$	284,000		-	-
	31-Dec-13
	Long-term debt	$	4,362,611	$	4,362,611		-	$	4,362,611
	Note receivable		1,921,046		2,365,000		-		2,365,000	-
	Marketable securities		278,000		278,000	$	278,000		-	-

Debt_Tables

Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	Debt at December 31, 2014 and 2013 consists of the following:
		2014		2013
	Term loan	$	3,067,442	$	2,400,697
	Revolving line of credit		500,000		1,150,000
	Obligation for acquisition of technology license, net		677,248		811,914
			4,244,690		4,362,611
	Less current maturities		697,423		581,004
	Long-term portion	$	3,547,267	$	3,781,607
Schedule of Maturities of Long-term Debt [Table Text Block]	Principal maturities of debt at December 31, 2014, are as follows:
	2015	$	697,423
	2016		3,320,019
	2017		227,248
	2018		-
	2019		-
	Thereafter		-
		$	4,244,690

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Employee Stock Option [Member]
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of the Company’s stock option activity and related information for the years ended December 31 follows:
		2014					2013
				Weighted				Weighted
				Avg.				Avg.
				Exercise				Exercise
		Options		Price			Options	Price
	Outstanding beginning of the year	1,465,000		$	3.42		1,313,500	$	3.95
	Granted	-					230,000		1.17
	Exercised	-					-
	Expired and forfeited	-83,000			2.4		-78,500		5.57
	Outstanding at end of year	1,382,000		$	3.49		1,465,000	$	3.42
	Exercisable at end of year	608,000		$	6.39		555,500	$	7.05
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]		As of December 31, 2014
		Options Outstanding						Options Exercisable
	Range of	Number		Weighted Avg.		Weighted Avg.		Number		Weighted Avg.		Weighted Avg.
	Exercise Prices	Outstanding		Remaining Life		Exercise Price		Exercisable		Remaining Life		Exercise Price
	$1.17	202,000		3.17		$	1.17	-		-		$	-
	$1.20 - $1.32	715,000		2			1.22	143,000		2			1.23
	$7.92	435,000		0.01			7.92	435,000		0.01			7.92
	$8.68	30,000		0.79			8.68	30,000		0.79			8.68
	$1.17 - $8.68	1,382,000		1.52		$	3.49	608,000		0.52		$	6.39
Warrant [Member]
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]	A summary of the Company’s warrant activity and related information for the years ended December 31 follows:
		2014					2013
				Weighted				Weighted
				Avg.				Avg.
				Exercise				Exercise
		Warrants		Price			Warrants	Price
	Outstanding beginning of the year	37,987		$	1.76		41,827	$	1.49
	Granted	11,192			1.17		12,065		2.81
	Exercised	-					-7,789		1.76
	Expired	-14,154			1.23		-8,116		1.94
	Outstanding at end of year	35,025		$	1.78		37,987	$	1.76
	Exercisable at end of year	35,025					37,987
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	The fair value of the warrants was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions:
		Year ended December 31
		2014		2013
	Expected warrant life (years)	3		3
	Risk-free weighted average interest rate	1.1	%	0.78	%
	Stock price volatility	64.1	%	62.8	%
	Dividend yield	0	%	0.8	%
Sharebased Compensation Intrinsic Value Actual Tax Benefit Realized And Cash Received [Table Text Block]	The intrinsic value for stock warrants outstanding at December 31, 2014 was $-0-. A summary of the total intrinsic value, actual tax benefit realized, and cash received for stock warrants exercised for the years ended December 31 follows:
		Year ended December 31
		2014			2013
	Stock Warrants Exercised:
	Intrinsic value	$	-		$	9,548
	Actual tax benefit realized		-			2,045
	Cash received		-			13,668
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
		As of December 31, 2014
		Warrants Outstanding						Warrants Exercisable
	Range of	Number		Weighted Avg.		Weighted Avg.		Number		Weighted Avg.
	Exercise Prices	Outstanding		Remaining Life		Exercise Price		Exercisable		Exercise Price
	$1.17	11,192		3		$	1.17	11,192		$	1.17
	$1.31	11,768		1			1.31	11,768			1.31
	$2.81	12,065		2			2.81	12,065			2.81
	$1.17 - $2.81	35,025		1.98		$	1.78	35,025		$	1.78

Earnings_per_Share_Tables

Earnings per Share (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted earnings per share:
		Year ended December 31
		2014		2013
	Numerator:
	Net income	$	724,569	$	776,590
	Denominator:
	Denominator for basic earnings per share – weighted average shares		12,666,000		12,619,000
	Dilutive effect of employee stock options and other warrants		145,000		197,000
	Denominator for diluted earnings per share – adjusted weighted average shares		12,811,000		12,816,000
	Basic earnings per share	$	0.06	$	0.06
	Diluted earnings per share	$	0.06	$	0.06

Leases_Tables

Leases (Tables)	12 Months Ended
	Dec. 31, 2014
Leases [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Future minimum payments under non-cancelable leases with initial or remaining terms in excess of one year consist of the following at December 31, 2014:
	2015	$	378,841
	2016		218,665
	2017		150,478
	2018		34,764
	2019		10,272
	Thereafter		5,136
		$	798,156

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	Compenents of income (loss) before income taxes:	Year ended December 31
		2014		2013
	United States	$	49,757	$	2,974,655
	Foreign		-73,188		-1,543,065
		$	-23,431	$	1,431,590
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Compenents of provision (benefit) for income taxes:	Year ended December 31
		2014		2013
	Current:
	Federal	$	-37,000	$	652,000
	State		-122,000		117,000
	Foreign		26,000		23,000
	Total current		-133,000		792,000
	Deferred:
	Federal		131,000		-126,000
	State		24,000		-23,000
	Foreign		-770,000		12,000
	Total deferred		-615,000		-137,000
		$	-748,000	$	655,000
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The provision (benefit) for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of 34%. The reasons for these differences are as follows:
		Year ended December 31
		2014		2013
	Income taxes at U.S. statutory rate	$	-8,000	$	487,000
	State income taxes, net of federal benefit		19,000		70,000
	Higher/(lower) effective taxes on earnings in foreign countries		37,000		116,000
	Foreign corporate income taxes		14,000		35,000
	Nondeductible meals and entertainment expense		23,000		27,000
	Qualified production activities income - AJCA		-		-52,000
	State tax planning strategy		-97,000		-
	Release of valuation allowance, net		-714,000		-
	Other		-22,000		-28,000
		$	-748,000	$	655,000
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The components of the deferred tax assets and liabilities, and the related tax effects of each temporary difference at December 31, 2014 and 2013, are as follows:
		2014		2013
	Deferred tax assets:
	Product refund reserve	$	13,000	$	26,000
	Inventory obsolescence reserve		24,000		28,000
	Vacation accrual		17,000		28,000
	Stock-based compensation		10,000		6,000
	Organization costs		208,000		207,000
	Deferred compensation		98,000		284,000
	Miscellaneous accrued expenses		8,000		16,000
	Foreign net operating loss carryforwards		3,147,000		3,640,000
	Valuation allowance - NOL carryforwards		-2,432,000		-3,640,000
			1,093,000		595,000
	Deferred tax liabilities:
	Depreciation and amortization		213,000		272,000
	Foreign currency exchange		133,000		141,000
			346,000		413,000
	Net deferred tax assets (liabilities)	$	747,000	$	182,000
	Reported as:
	Current deferred tax assets	$	61,000	$	309,000
	Non-current deferred tax assets		686,000		-
	Non-current deferred tax liabilities		-		127,000
	Net deferred tax assets	$	747,000	$	182,000
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	The aggregate changes in the balance of gross unrecognized tax benefits were as follows:
	Beginning balance as of January 1, 2013	$	56,000
	Settlements and effective settlements with tax authorities		-
	Lapse of statute of limitations		-7,000
	Increases in balances related to tax positions taken during prior periods		40,000
	Decreases in balances related to tax positions taken during prior periods		-11,000
	Increases in balances related to tax positions taken during current period		13,000
	Balance as of December 31, 2013	$	91,000
	Settlements and effective settlements with tax authorities		-
	Lapse of statute of limitations		-6,000
	Increases in balances related to tax positions taken during prior periods		-
	Decreases in balances related to tax positions taken during prior periods		-46,000
	Increases in balances related to tax positions taken during current period		9,000
	Balance as of December 31, 2014	$	48,000

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Geographic area data for the years ended December 31, 2014 and 2013 follow:
			2014		2013
	Net sales to external customers
	United States		$	43,323,190	$	53,650,647
	Australia/New Zealand			1,641,492		1,858,983
	Canada			1,367,294		1,776,375
	Mexico			796,208		977,358
	Europe   (1)			8,300,520		7,953,221
	Asia   (2)			1,916,255		1,990,154
	Total net sales		$	57,344,959	$	68,206,738
	Assets by area
	United States		$	22,414,373	$	22,966,040
	Australia/New Zealand			609,933		807,336
	Canada			485,544		753,035
	Mexico			456,601		531,854
	Europe   (1)			2,244,738		1,665,194
	Asia   (2)			636,621		875,292
	Total consolidated assets		$	26,847,810	$	27,598,751
	-1	Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.
	-2	Asia consists of Philippines, Malaysia, Singapore, and Indonesia.
ScheduleOfSegmentReportingInformationByProductTextBlock [Table Text Block]	The Company classifies its sales into three categories of sales products plus handling & freight income. Net sales by product category data for the years ended December 31, 2014 and 2013, follow:
			2014		2013
	Net sales by product category
	Nutritional and dietary supplements		$	51,144,929	$	60,049,651
	Skin care products			344,325		417,688
	Sales aids and other			1,413,000		1,912,111
	Handling & freight income			4,442,705		5,827,288
	Total net sales		$	57,344,959	$	68,206,738

Nature_of_Business_and_Signifi2

Nature of Business and Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment, Depreciation Methods	straight-line or an accelerated method
Foreign currency transaction (gain)/loss	$136,999	$126,188
Revenue Recognition Determination Of Selling Price Method	Generally, net sales reflect product sales less the distributor discount of 20 percent to 40 percent of the suggested retail price.
Revenue Recognition Description Of Sales Returns	Allowable returns are limited to saleable product which was purchased within twelve months of the termination for a refund of 90% of the original purchase price less any distributor royalties and commission received relating to the original purchase of the returned products
Sales Returns Goods Percentage	0.25%	0.57%
Advertising Expense	19,400	191,800
Research and Development Expense	$618,000	$565,000

Property_Plant_and_Equipment_D

Property, Plant, and Equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Land and land improvements	$883,563	$883,563
Building	9,966,748	9,945,187
Machinery and equipment	4,355,040	3,785,949
Office equipment	1,235,192	1,236,303
Computer equipment and software	2,505,229	2,690,294
Property, plant, and equipment,Gross	18,945,772	18,541,296
Less accumulated depreciation	12,019,802	11,805,877
Property, plant, and equipment, net	$6,925,970	$6,735,419

Property_Plant_and_Equipment_D1

Property, Plant, and Equipment (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation	$691,603	$750,267

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Accounts Payable and Accrued Liabilities [Line Items]
Trade payables	$2,026,198	$2,968,814
Distributors' commissions	1,753,908	2,033,727
Sales taxes	292,188	311,049
Payroll, payroll taxes, and incentive compensation payable	1,114,763	555,193
Accounts Payable and Accrued Liabilities, Current	$5,187,057	$5,868,783

Amortizable_Intangible_Assets_1

Amortizable Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Amortizable Intangible Assets [Line Items]
Gross Carrying Amount	$4,014,661	$4,014,661
Accumulated Amortization	1,088,886	818,758
Distributorship [Member]
Amortizable Intangible Assets [Line Items]
Gross Carrying Amount	2,060,000	2,060,000
Accumulated Amortization	924,385	770,375
Technology-Based Intangible Assets [Member]
Amortizable Intangible Assets [Line Items]
Gross Carrying Amount	1,954,661	1,954,661
Accumulated Amortization	$164,501	$48,383

Amortizable_Intangible_Assets_2

Amortizable Intangible Assets (Detail 1) (USD $)	Dec. 31, 2014
Finite-lived Intangible Assets Amortization Expense [Line Items]
2015	$270,000
2016	255,000
2017	226,000
2018	226,000
2019	$226,000

Amortizable_Intangible_Assets_3

Amortizable Intangible Assets (Details Textuals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule Of Amortizable Intangible Assets [Line Items]
Amortization of Intangible Assets	$270,128	$202,393

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Value	$4,244,690	$4,362,611
Note receivable, Carrying Value	1,829,827	1,921,046
Marketable securities, Carrying Value	284,000	278,000
Long-term debt, Fair Value	4,244,690	4,362,611
Note receivable, Fair Value	2,098,000	2,365,000
Marketable securities, Fair Value	284,000	278,000
Fair Value, Inputs, Level 1 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Value	0	0
Note receivable, Carrying Value	0	0
Marketable securities, Carrying Value	284,000	278,000
Fair Value, Inputs, Level 2 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Value	4,244,690	4,362,611
Note receivable, Carrying Value	2,098,000	2,365,000
Marketable securities, Carrying Value	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Value	0
Note receivable, Carrying Value		0
Marketable securities, Carrying Value	$0	$0

Debt_Details

Debt (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Carrying Value Of Debt [Line Items]
Term loan	$3,067,442	$2,400,697
Revolving line of credit	500,000	1,150,000
Long-term Debt	4,244,690	4,362,611
Less current maturities	697,423	581,004
Long-term portion	3,547,267	3,781,607
Obligation For Acquisition Of Technology License [Member]
Carrying Value Of Debt [Line Items]
Obligation for acquisition of technology license, net	$677,248	$811,914

Debt_Details_1

Debt (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Twelve months ending December 31,
2015	$697,423
2016	3,320,019
2017	227,248
2018	0
2019	0
Thereafter	0
Long-term Debt, Total	$4,244,690	$4,362,611

Debt_Details_Textual

Debt (Details Textual) (USD $)	12 Months Ended		1 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2012	Feb. 28, 2014
Carrying Value Of Debt [Line Items]
Long-term Line of Credit	$500,000	$1,150,000
Proceeds from Lines of Credit	500,000	1,150,000
Technology License [Member]
Carrying Value Of Debt [Line Items]
Technology License Agreement Periodic Payment Range Minimum Amount	150,000
Technology License Agreement Periodic Payment Range Maximum Amount	250,000
Finite-lived Intangible Assets Acquired	2,000,000
Technology License Agreement Percentage Of Royalties One Through Five Years	5.00%
Technology License [Member] | Minimum [Member]
Carrying Value Of Debt [Line Items]
Technology License Agreement Percentage Of Royalties Remaining Life	1.00%
Technology License [Member] | Maximum [Member]
Carrying Value Of Debt [Line Items]
Technology License Agreement Percentage Of Royalties Remaining Life	3.00%
Second Amendment [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Restrictive Covenants	the Second Amendment revises the net tangible worth covenant to a covenant minimum of $9.5 million and re-defines net tangible worth as actual stockholders equity reduced by the sum of net intangible assets, accounts due from employees and distributors, and note receivable due from distributor.
Revolving Credit Facility [Member]
Carrying Value Of Debt [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,500,000	5,000,000	3,500,000
Line of Credit Facility, Remaining Borrowing Capacity	3,000,000
Line of Credit Facility, Interest Rate Description				variable interest rate based on 30-day LIBOR + 1.85%
Line of Credit Facility, Interest Rate at Period End	2.01%
Proceeds from Lines of Credit			500,000
Credit Agreement [Member]
Carrying Value Of Debt [Line Items]
Long-term Line of Credit					1,150,000
Secured Debt [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Description Of Variable Rate Basis				a floating interest rate based on the 30-day LIBOR plus 2%.
Debt Instrument, Frequency Of Periodic Payment	Monthly
Debt Instrument, Periodic Payment, Principal	$41,452
Debt Instrument, Maturity Date	1-Jul-16			30-Nov-15
Debt Instrument, Interest Rate During Period	2.16%
Debt Instrument, Term	28 months
Debt Instrument, Restrictive Covenants	The Credit Agreement also includes loan covenants requiring the Company to maintain net tangible worth of not less than $11 million, and a fixed charge coverage ratio under which EBITDA adjusted for certain non-cash expenses shall exceed fixed charges by a ratio of at least 1.15 to 1.

Stockholders_Equity_Details

Stockholders' Equity (Details) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding beginning of the year	1,465,000	1,313,500
Options Granted	0	230,000
Options Exercised	0	0
Options Expired and forfeited	-83,000	-78,500
Outstanding at end of year	1,382,000	1,465,000
Exercisable at end of year	608,000	555,500
Weighted Avg. Exercise Price Outstanding beginning of the year (in dollars per share)	$3.42	$3.95
Weighted Avg. Exercise Price Granted (in dollars per share)		$1.17
Weighted Avg. Exercise Price Expired and forfeited (in dollars per share)	$2.40	$5.57
Weighted Avg. Exercise Price Outstanding at end of year (in dollars per share)	$3.49	$3.42
Weighted Avg. Exercise Price Exercisable at end of year (in dollars per share)	$6.39	$7.05

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$1.17
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$8.68
Number Options Outstanding	1,382,000
Options Outstanding, Weighted Avg. Remaining Life (in years)	1 year 6 months 7 days
Options Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$3.49
Number Options Exercisable	608,000
Options Exercisable, Weighted Avg. Remaining Life (in years)	6 months 7 days
Options Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$6.39
Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices (in dollars per share)	$1.17
Number Options Outstanding	202,000
Options Outstanding, Weighted Avg. Remaining Life (in years)	3 years 2 months 1 day
Options Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$1.17
Number Options Exercisable	0
Options Exercisable, Weighted Avg. Remaining Life (in years)	0 years
Options Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$0
Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$1.20
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$1.32
Number Options Outstanding	715,000
Options Outstanding, Weighted Avg. Remaining Life (in years)	2 years
Options Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$1.22
Number Options Exercisable	143,000
Options Exercisable, Weighted Avg. Remaining Life (in years)	2 years
Options Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$1.23
Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices (in dollars per share)	$7.92
Number Options Outstanding	435,000
Options Outstanding, Weighted Avg. Remaining Life (in years)	4 days
Options Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$7.92
Number Options Exercisable	435,000
Options Exercisable, Weighted Avg. Remaining Life (in years)	4 days
Options Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$7.92
Exercise Price Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices (in dollars per share)	$8.68
Number Options Outstanding	30,000
Options Outstanding, Weighted Avg. Remaining Life (in years)	9 months 14 days
Options Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$8.68
Number Options Exercisable	30,000
Options Exercisable, Weighted Avg. Remaining Life (in years)	9 months 14 days
Options Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$8.68

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (Warrant [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected warrant life (years)	3 years	3 years
Risk-free weighted average interest rate	1.10%	0.78%
Stock price volatility	64.10%	62.80%
Dividend yield	0.00%	0.80%

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding beginning of the year	37,987	41,827
Warrants Granted	11,192	12,065
Warrants Exercised	0	-7,789
Warrants Expired	-14,154	-8,116
Outstanding at end of year	35,025	37,987
Exercisable at end of year	35,025	37,987
Weighted Avg. Exercise Price Outstanding beginning of the year (in dollars per share)	$1.76	$1.49
Weighted Avg. Exercise Price Granted (in dollars per share)	$1.17	$2.81
Weighted Avg. Exercise Price Exercised (in dollars per share)		$1.76
Weighted Avg. Exercise Price Expired (in dollars per share)	$1.23	$1.94
Weighted Avg. Exercise Price Outstanding at end of year (in dollars per share)	$1.78	$1.76

Stockholders_Equity_Details_4

Stockholders' Equity (Details 4) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding	35,025
Warrants Outstanding, Weighted Avg. Remaining Life	1 year 11 months 23 days
Warrants Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$1.78
Number Warrants Exercisable	35,025
Warrants Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$1.78
Range of Exercise Prices (in dollars per share)	$1.78
Range of Exercise Prices, Lower Range Limit (in dollars per share)	$1.17
Range of Exercise Prices, Upper Range Limit (in dollars per share)	$2.81
Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding	11,192
Warrants Outstanding, Weighted Avg. Remaining Life	3 years
Warrants Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$1.17
Number Warrants Exercisable	11,192
Warrants Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$1.17
Range of Exercise Prices (in dollars per share)	$1.17
Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding	11,768
Warrants Outstanding, Weighted Avg. Remaining Life	1 year
Warrants Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$1.31
Number Warrants Exercisable	11,768
Warrants Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$1.31
Range of Exercise Prices (in dollars per share)	$1.31
Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding	12,065
Warrants Outstanding, Weighted Avg. Remaining Life	2 years
Warrants Outstanding, Weighted Avg. Exercise Price (in dollars per share)	$2.81
Number Warrants Exercisable	12,065
Warrants Exercisable, Weighted Avg. Exercise Price (in dollars per share)	$2.81
Range of Exercise Prices (in dollars per share)	$2.81

Stockholders_Equity_Details_5

Stockholders' Equity (Details 5) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Warrants Exercised:
Intrinsic value	$0	$9,548
Actual tax benefit realized	0	2,045
Cash received	$0	$13,668

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Jul. 31, 2009
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Services	$176,499
Consulting Services [Member]
Class of Stock [Line Items]
Professional Fees	70,499	106,000
Warrant [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	11,192	12,065
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$1.17	$2.81
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.10%	0.78%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	64.10%	62.80%
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Services	153
Employee Stock Option [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	230,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$1.17
Incentive Stock Plan 2009 [Member]
Class of Stock [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	60,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		0.90%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate		1.60%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		52.70%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$0.48
Incentive Stock Plan 2009 [Member] | Performance Based Stock Options [Member]
Class of Stock [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options		110,400
Incentive Stock Plan 2009 [Member] | Employee Stock Option [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			230,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$1.17
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options, Net of Tax	58,000
Allocated Share-based Compensation Expense	32,737	36,772
Allocated Share-based Compensation Expense, Net of Tax	32,000	35,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	10 years
Distributor Stock Purchase Plan 2009 [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				68,263
Percentage Of Monthly Compensation To Purchase Common Stock	10.00%
Warrant Issued Percentage	25.00%
Distributor Stock Purchase Plan 2009 [Member] | Warrant [Member]
Class of Stock [Line Items]
Allocated Share-based Compensation Expense	13,633	4,973
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$0

Earnings_per_Share_Details

Earnings per Share (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Numerator:
Net Income (Loss) Attributable to Parent, Total	$724,569	$776,590
Denominator:
Denominator for basic earnings per share - weighted average shares	12,666,000	12,619,000
Dilutive effect of employee stock options and other warrants	145,000	197,000
Denominator for diluted earnings per share - adjusted weighted average shares	12,811,000	12,816,000
Basic earnings per share	$0.06	$0.06
Diluted earnings per share	$0.06	$0.06

Earnings_per_Share_Details_Tex

Earnings per Share (Details Textual)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,036,565	1,099,565

Leases_Details

Leases (Details) (USD $)	Dec. 31, 2014
Operating Leased Assets [Line Items]
2015	$378,841
2016	218,665
2017	150,478
2018	34,764
2019	10,272
Thereafter	5,136
Operating Leases, Future Minimum Payments Due	$798,156

Leases_Details_Textual

Leases (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense	$471,066	$479,862

Note_Receivable_Due_From_Distr1

Note Receivable Due From Distributor (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes Receivable, Related Parties	1,829,827	$1,921,046
Loan Modification Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Due from Related Parties			2,000,000
Loans Receivable, Description of Variable Rate Basis	greater of 6% or prime	monthly payment of principal and interest
Real Estate Investment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Due from Related Parties			$2,000,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Before Income Tax, Domestic and Foreign [Line Items]
United States	$49,757	$2,974,655
Foreign	-73,188	-1,543,065
Income before income taxes	($23,431)	$1,431,590

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Current:
Federal	($37,000)	$652,000
State	-122,000	117,000
Foreign	26,000	23,000
Total current	-133,000	792,000
Deferred:
Federal	131,000	-126,000
State	24,000	-23,000
Foreign	-770,000	12,000
Total deferred	-615,000	-137,000
Income Tax Expense (Benefit)	($748,000)	$655,000

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Provision Benefit For Income Taxes [Line Items]
Income taxes at U.S. statutory rate	($8,000)	$487,000
State income taxes, net of federal benefit	19,000	70,000
Higher/(lower) effective taxes on earnings in foreign countries	37,000	116,000
Foreign corporate income taxes	14,000	35,000
Nondeductible meals and entertainment expense	23,000	27,000
Qualified production activities income - AJCA	0	-52,000
State tax planning strategy	-97,000	0
Release of valuation allowance, net	-714,000	0
Other, net	-22,000	-28,000
Income Tax Expense (Benefit), Total	($748,000)	$655,000

Income_Taxes_Details_3

Income Taxes (Details 3) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Product refund reserve	$13,000	$26,000
Inventory obsolescence reserve	24,000	28,000
Vacation accrual	17,000	28,000
Stock-based compensation	10,000	6,000
Organization costs	208,000	207,000
Deferred compensation	98,000	284,000
Miscellaneous accrued expenses	8,000	16,000
Foreign net operating loss carryforwards	3,147,000	3,640,000
Valuation allowance - NOL carryforwards	-2,432,000	-3,640,000
Deferred Tax Assets, Net of Valuation Allowance	1,093,000	595,000
Deferred tax liabilities:
Depreciation and amortization	213,000	272,000
Foreign currency exchange	133,000	141,000
Deferred Tax Liabilities, Gross	346,000	413,000
Net deferred tax assets (liabilities)	747,000	182,000
Reported as:
Current deferred tax assets	61,000	309,000
Non-current deferred tax assets	686,000	0
Non-current deferred tax liabilities	0	127,000
Net deferred tax assets	$747,000	$182,000

Income_Taxes_Details_4

Income Taxes (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets and Liabilities [Line Items]
Beginning balance	$91,000	$56,000
Settlements and effective settlements with tax authorities	0	0
Lapse of statute of limitations	-6,000	-7,000
Increases in balances related to tax positions taken during prior periods	0	40,000
Decreases in balances related to tax positions taken during prior periods	-46,000	-11,000
Increases in balances related to tax positions taken during current period	9,000	13,000
Ending Balance	$48,000	$91,000

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended			36 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2010	Dec. 31, 2006	Dec. 31, 2012
Income Taxes [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%
Deferred Tax Assets, Operating Loss Carryforwards, Foreign	$3,147,000	$3,640,000
Unrecognized Tax Benefits	48,000	91,000			56,000
Vat And Withholding Taxes				800,000
Interest Penalty Percentage				20.00%
Selling, General and Administrative Expense			185,000
Management Estimated Reserve For Tax	122,000
Undistributed Earnings of Foreign Subsidiaries	57,000
Valuation Allowance, Deferred Tax Asset, Amount	3,600,000
Income Tax Expense (Benefit)	$748,000	($655,000)

Employee_Benefit_Plans_Details

Employee Benefit Plans (Details Textual) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan Contributions By Plan Participants Percentage			15.00%
Employer Matching Contribution Percentage	10.00%	25.00%		25.00%
Defined Benefit Plan, Contributions by Employer			$98,300	$144,600
Employee Stock Ownership Plan ESOP Fair Value Contributions To ESOP			$0	$125,000

Incentive_Compensation_Plans_D

Incentive Compensation Plans (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Incentive Compensation Plans [Line Items]
Other Selling, General and Administrative Expense	$25,048,596	$27,755,483
Other Liabilities, Noncurrent	418,785	910,327
Supplemental Employer Retirement Plan, Defined Contribution [Member]
Incentive Compensation Plans [Line Items]
Supplemental Executive Retirement Plan Employer Matching Contribution Percent	100.00%
Asset Retirement Obligation, Legally Restricted Assets, Fair Value	284,000	278,000
Deferred Compensation Liability, Classified, Noncurrent	288,000	287,000
Incentive Compensation Plan [Member]
Incentive Compensation Plans [Line Items]
Other Selling, General and Administrative Expense	137,000	440,500
Other Liabilities, Noncurrent		529,000
Payroll Payroll Taxes And Incentive Compensation Payable	666,000
Percentage Of Bonus Under Incentive Compensation Plan	16.00%	16.00%
Maximum Percentage Of Bonus Under Incentive Compensation Plan	18.00%	18.00%
Incentive Compensation Annual Management	89,000	286,000
Minimum Quarterly Income From Operations	$500,000
Performance Based Incentive Compensation Vest Based On Annual Increment Percentage	20.00%

Segment_Information_Details

Segment Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$57,344,959		$68,206,738
Total assets	26,847,810		27,598,751
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	43,323,190		53,650,647
Total assets	22,414,373		22,966,040
Australia/NewZealand [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,641,492		1,858,983
Total assets	609,933		807,336
Canada [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,367,294		1,776,375
Total assets	485,544		753,035
Mexico [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	796,208		977,358
Total assets	456,601		531,854
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	8,300,520	[1]	7,953,221	[1]
Total assets	2,244,738	[1]	1,665,194	[1]
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,916,255	[2]	1,990,154	[2]
Total assets	$636,621	[2]	$875,292	[2]
[1]	Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.
[2]	Asia consists of Philippines, Malaysia, Singapore, and Indonesia.

Segment_Information_Details_1

Segment Information (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Total net sales	$57,344,959	$68,206,738
Nutritional And Dietary Supplements [Member]
Segment Reporting Information [Line Items]
Total net sales	51,144,929	60,049,651
Skin Care Products [Member]
Segment Reporting Information [Line Items]
Total net sales	344,325	417,688
Sales Aids and Other [Member]
Segment Reporting Information [Line Items]
Total net sales	1,413,000	1,912,111
Handling And Freight Income [Member]
Segment Reporting Information [Line Items]
Total net sales	$4,442,705	$5,827,288